New ALS drug slips through telling ‘phase II’ clinical trials
January 3, 2010 by admin
 | We comply with the HONcode standard for trustworthy health information: verify here. |
Featured Video
Categories
- Medical News
- Cancer Treatment
- Breast Cancer
- Prostate & Testicular Cancers
- Cervical - Endometrial - Ovarian - Uterine - Womb Cance
- Leukemia
- Colon - Rectal - Corectal Cancers
- Esophageal, Oral, Tongue, Throat, Neck, Head Cancers
- Melanoma - Skin Cancer
- Lung Cancer
- Hodgkins & Non-Hodgkins Lymphoma
- Pancreatic Cancer
- Stomach & Gastric Cancer
- Viral & Infection News
- Brain News & Ailments
- Genetics - Gene Therapy
- Stem Cell Research
- Heart Disease
- FDA NEWS DIGEST
- Alzheimers - Dementia
- Breakthrough Digest Medical News
- Diabetes
- Vaccines
- AIDS - HIV
- Gastrointestinal - IBD
- Obesity
- Tumors
- Women's Health
- Arthritis, Gout, & Joint Disease
- Parkinson Disease
- Eye Ailments
- Aging
- Stroke
- Multiple Sclerosis (MS)
- lung News & Ailments
- Hepatitis
- Autism
- Depression
- Nanotechnology
- Spinal Injuries
- Kidney Ailments
- Hypertension
- Schizophrenia
- Tuberculosis (TB)
- Malaria
- Huntington
- Liver Ailments
- Asthma
- Lou Gehrig Disease (ALS)
- Muscular Dystrophy
Comments